167 related articles for article (PubMed ID: 34738326)
21. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
Attallah AM; El-Far M; Omran MM; Abdallah SO; El-Desouky MA; El-Dosoky I; Abdelrazek MA; Attallah AA; Elweresh MA; Abdel Hameed GE; Shawki HA; Salama KS; El-Waseef AM
Tumour Biol; 2014 Nov; 35(11):10737-45. PubMed ID: 25073515
[TBL] [Abstract][Full Text] [Related]
22. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
23. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of Sema4C in esophageal cancer, gastric cancer and rectal cancer].
Ye SM; Han M; Kan CY; Yang LL; Yang J; Ma QF; Wang SX
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(28):1954-8. PubMed ID: 22944267
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Serum Integrin αvβ3 & Vitronectin in the Early Diagnosis of Breast Cancer.
Radwan AF; Ismael OE; Fawzy A; El-Mesallamy HO
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307158
[TBL] [Abstract][Full Text] [Related]
26. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
[TBL] [Abstract][Full Text] [Related]
27. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
28. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract][Full Text] [Related]
29. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
Makawita S; Dimitromanolakis A; Soosaipillai A; Soleas I; Chan A; Gallinger S; Haun RS; Blasutig IM; Diamandis EP
BMC Cancer; 2013 Sep; 13():404. PubMed ID: 24007603
[TBL] [Abstract][Full Text] [Related]
30. Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138+ Plasma Cells.
Xue D; Kaufman GN; Dembele M; Beland M; Massoud AH; Mindt BC; Fiter R; Fixman ED; Martin JG; Friedel RH; Divangahi M; Fritz JH; Mazer BD
J Immunol; 2017 Jan; 198(1):71-81. PubMed ID: 27881703
[TBL] [Abstract][Full Text] [Related]
31. Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.
Leung F; Dimitromanolakis A; Kobayashi H; Diamandis EP; Kulasingam V
Clin Biochem; 2013 Oct; 46(15):1462-8. PubMed ID: 23528302
[TBL] [Abstract][Full Text] [Related]
32. Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation.
Nyren-Erickson EK; Bouton M; Raval M; Totzauer J; Mallik S; Alberto N
J Negat Results Biomed; 2014 Apr; 13():5. PubMed ID: 24690292
[TBL] [Abstract][Full Text] [Related]
33. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
34. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH
J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634
[TBL] [Abstract][Full Text] [Related]
35. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
36. Role of Sema4C in TGF-β1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Zeng R; Han M; Luo Y; Li C; Pei G; Liao W; Bai S; Ge S; Liu X; Xu G
Nephrol Dial Transplant; 2011 Apr; 26(4):1149-56. PubMed ID: 20959347
[TBL] [Abstract][Full Text] [Related]
37. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
38. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
Mellby LD; Nyberg AP; Johansen JS; Wingren C; Nordestgaard BG; Bojesen SE; Mitchell BL; Sheppard BC; Sears RC; Borrebaeck CAK
J Clin Oncol; 2018 Oct; 36(28):2887-2894. PubMed ID: 30106639
[TBL] [Abstract][Full Text] [Related]
39. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.
Mao J; Ladd J; Gad E; Rastetter L; Johnson MM; Marzbani E; Childs JS; Lu H; Dang Y; Broussard E; Stanton SE; Hanash SM; Disis ML
J Transl Med; 2014 May; 12():121. PubMed ID: 24886063
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
